Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect.
Brewerton
T D
TD
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced*; D008094:Lithium / Q000627:therapeutic use*
D002220:Carbamazepine; D008094:Lithium; D006220:Haloperidol